Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis I Spuls

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Expert Opinion on Drug Safety|February 16, 2023
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesHelen R Gosselt, Jette A van Lint, Leanne J Kosse, et al.
The Journal of Investigative Dermatology|March 25, 2014
Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patientsMarcel B M Teunissen, J Marius Munneke, Jochem H Bernink, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2024
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi studyAnouk G M Caron, Astrid M van Huizen, Annelie A H Musters, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 7, 2025
Measuring health-related quality of life in patients with peripheral vascular malformations with PROMIS® computerized adaptive testsDelano J de Oliveira Marreiros, Max M Lokhorst, Danny A Young-Afat, et al.
The Cochrane Database of Systematic Reviews|October 28, 2021
Phototherapy for atopic eczemaAnnelie H Musters, Soudeh Mashayekhi, Jane Harvey, et al.
Trials|March 1, 2017
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registriesLouise A A Gerbens, Aaron E Boyce, Dmitri Wall, et al.
The British Journal of Dermatology|June 12, 2024
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosaEva W H Korte, Anna M G Pasmooij, Maria C Bolling, et al.
Expert Opinion on Drug Safety|January 21, 2022
Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionalsIsa P A C Geeven, Naomi T Jessurun, Arthur T M Wasylewicz, et al.
Drug Safety|May 27, 2020
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory DiseasesJette A van Lint, Naomi T Jessurun, Renske C F Hebing, et al.
The Journal of Rheumatology|May 16, 2021
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare ProfessionalsJette A van Lint, Naomi T Jessurun, Sander W Tas, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Safety|February 16, 2023
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesHelen R Gosselt, Jette A van Lint, Leanne J Kosse, et al.
The Journal of Investigative Dermatology|March 25, 2014
Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patientsMarcel B M Teunissen, J Marius Munneke, Jochem H Bernink, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 1, 2024
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi studyAnouk G M Caron, Astrid M van Huizen, Annelie A H Musters, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 7, 2025
Measuring health-related quality of life in patients with peripheral vascular malformations with PROMIS® computerized adaptive testsDelano J de Oliveira Marreiros, Max M Lokhorst, Danny A Young-Afat, et al.
The Cochrane Database of Systematic Reviews|October 28, 2021
Phototherapy for atopic eczemaAnnelie H Musters, Soudeh Mashayekhi, Jane Harvey, et al.
Trials|March 1, 2017
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registriesLouise A A Gerbens, Aaron E Boyce, Dmitri Wall, et al.
The British Journal of Dermatology|June 12, 2024
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosaEva W H Korte, Anna M G Pasmooij, Maria C Bolling, et al.
Expert Opinion on Drug Safety|January 21, 2022
Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionalsIsa P A C Geeven, Naomi T Jessurun, Arthur T M Wasylewicz, et al.
Drug Safety|May 27, 2020
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory DiseasesJette A van Lint, Naomi T Jessurun, Renske C F Hebing, et al.
The Journal of Rheumatology|May 16, 2021
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare ProfessionalsJette A van Lint, Naomi T Jessurun, Sander W Tas, et al.
Pageof 13